A randomized, controlled, parallel group design will be used to test whether a Secondhand Smoke Exposure program initiated in the hospital and completed in the home using motivational interviewing plus motivational incentives (MI+) is more effective than Conventional Care (CC) with Neonatal Incentives Care Unit Infants' parents.

Primary caregiver reports via the Timeline Follow-Back and household air nicotine monitors. Number of cigarettes smoked outdoors vs. indoor and the implementation of household smoking bans will also be assessed. Primary caregivers will complete the SHSe related interviews and self-report questionnaires. Primary caregivers who are smokers will complete measures related to smoking and smoking cessation.

Attendance at each session and for the establishment of a household smoking ban at two timepoints post-discharge

Conventional Care (CC)

Behavioral: Conventional Care (CC)

Participants in this arm will receive brochures and a brief information meeting in the NICU.

Eligibility

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

Yes

Criteria

Inclusion Criteria:

Have an infant that is at least 1 week prior to the estimated date of hospital discharge in the NICU at Children's Memorial Hermann Hospital (CMHH)

Report at least one person living in the home who smokes

Agree to attend intervention sessions and to invite other household members

Live within 50 miles of our center

Have access to a telephone.

Exclusion Criteria:

Severe cognitive, and/or psychiatric impairment, per judgment of NICU and research staff, that precludes cooperation with study protocol

Inability to read, write, and speak English or Spanish

Inability or unwillingness to provide signed consent for participation

Inability or unwillingness to meet study requirements, including home visits for data collection and intervention purposes.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01726062